Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia.
Clark
Christopher M
CM
Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. chris.clark@uphs.upenn.edu
Pratico
Domenico
D
Shaw
Lesley M
LM
Leight
Susan
S
Xie
Sharon X
SX
Gu
Amy
A
Lee
Virginia M-Y
VM
Trojanowski
John Q
JQ